BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15644416)

  • 1. Negative thymocyte selection to HERV-K18 superantigens in humans.
    Meylan F; De Smedt M; Leclercq G; Plum J; Leupin O; Marguerat S; Conrad B
    Blood; 2005 Jun; 105(11):4377-82. PubMed ID: 15644416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity.
    Stauffer Y; Marguerat S; Meylan F; Ucla C; Sutkowski N; Huber B; Pelet T; Conrad B
    Immunity; 2001 Oct; 15(4):591-601. PubMed ID: 11672541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Viral superantigens].
    Us D
    Mikrobiyol Bul; 2016 Jul; 50(3):491-504. PubMed ID: 27525406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen.
    Sutkowski N; Conrad B; Thorley-Lawson DA; Huber BT
    Immunity; 2001 Oct; 15(4):579-89. PubMed ID: 11672540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of human endogenous retrovirus HERV-K18 superantigen is elevated in juvenile rheumatoid arthritis.
    Sicat J; Sutkowski N; Huber BT
    J Rheumatol; 2005 Sep; 32(9):1821-31. PubMed ID: 16142883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine Vbeta3+ and Vbeta7+ T cell subsets are specific targets for the HERV-K18 Env superantigen.
    Tai AK; Lin M; Chang F; Chen G; Hsiao F; Sutkowski N; Huber BT
    J Immunol; 2006 Sep; 177(5):3178-84. PubMed ID: 16920956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human herpesvirus-6B induces expression of the human endogenous retrovirus K18-encoded superantigen.
    Turcanova VL; Bundgaard B; Höllsberg P
    J Clin Virol; 2009 Sep; 46(1):15-9. PubMed ID: 19505847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HHV-6A infection induces expression of HERV-K18-encoded superantigen.
    Tai AK; Luka J; Ablashi D; Huber BT
    J Clin Virol; 2009 Sep; 46(1):47-8. PubMed ID: 19505843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neither an intronic CA repeat within the CD48 gene nor the HERV-K18 polymorphisms are associated with type 1 diabetes.
    Ramos-Lopez E; Ghebru S; Van Autreve J; Aminkeng F; Herwig J; Seifried E; Seidl C; Van der Auwera B; Badenhoop K
    Tissue Antigens; 2006 Aug; 68(2):147-52. PubMed ID: 16866884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human endogenous retrovirus-K18 Env as a risk factor in multiple sclerosis.
    Tai AK; O'Reilly EJ; Alroy KA; Simon KC; Munger KL; Huber BT; Ascherio A
    Mult Scler; 2008 Nov; 14(9):1175-80. PubMed ID: 18701576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus latent membrane protein LMP-2A is sufficient for transactivation of the human endogenous retrovirus HERV-K18 superantigen.
    Sutkowski N; Chen G; Calderon G; Huber BT
    J Virol; 2004 Jul; 78(14):7852-60. PubMed ID: 15220463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of mouse mammary tumor virus superantigen mRNA in the thymus correlates with kinetics of self-reactive T-cell loss.
    Barnett A; Mustafa F; Wrona TJ; Lozano M; Dudley JP
    J Virol; 1999 Aug; 73(8):6634-45. PubMed ID: 10400761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and presentation of endogenous mouse mammary tumor virus superantigens by thymic and splenic dendritic cells and B cells.
    Ardavín C; Waanders G; Ferrero I; Anjuère F; Acha-Orbea H; MacDonald HR
    J Immunol; 1996 Oct; 157(7):2789-94. PubMed ID: 8816381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EBV LMP-2A employs a novel mechanism to transactivate the HERV-K18 superantigen through its ITAM.
    Hsiao FC; Tai AK; Deglon A; Sutkowski N; Longnecker R; Huber BT
    Virology; 2009 Mar; 385(1):261-6. PubMed ID: 19070345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superantigens are presented by and activate thymocytes from infants.
    Thulesen S; Jørgensen A; Gerwien J; Dohlsten M; Holst Nissen M; Odum N; Röpke C
    Exp Clin Immunogenet; 1999; 16(4):226-33. PubMed ID: 10575276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro negative selection of viral superantigen-reactive thymocytes by thymic dendritic cells.
    Ferrero I; Anjuère F; MacDonald HR; Ardavín C
    Blood; 1997 Sep; 90(5):1943-51. PubMed ID: 9292528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of human endogenous retrovirus K-18 polymorphisms with type 1 diabetes.
    Marguerat S; Wang WY; Todd JA; Conrad B
    Diabetes; 2004 Mar; 53(3):852-4. PubMed ID: 14988274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: Epstein-Barr virus transactivates the HERV-K18 superantigen by docking to the human complement receptor 2 (CD21) on primary B cells.
    Hsiao FC; Lin M; Tai A; Chen G; Huber BT
    J Immunol; 2006 Aug; 177(4):2056-60. PubMed ID: 16887963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human thymic epithelial cells present superantigens to T-cell lines and thymocytes.
    Jłrgensen A; Nielsen M; Svejgaard A; Ledbetter JA; Odum N; Röpke C
    Exp Clin Immunogenet; 1996; 13(3-4):192-203. PubMed ID: 9165273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of human endogenous retrovirus HERV-K18 is associated with clinical severity in osteoarthritis patients.
    Garcia-Montojo M; Varade J; Villafuertes E; de La Hera B; Hoyas-Fernandez J; Domínguez-Mozo MI; Rodriguez-Rodriguez L; Tornero-Esteban P; Arias-Leal A; León L; Lamas JR; Alvarez-Lafuente R; Urcelay E; Fernandez-Gutierrez B
    Scand J Rheumatol; 2013; 42(6):498-504. PubMed ID: 23662747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.